Literature DB >> 1473415

Morbidity and mortality of wide pelvic lymphadenectomy for rectal adenocarcinoma.

F Michelassi1, G E Block.   

Abstract

This retrospective study was aimed at defining the morbidity and mortality of a radical resection for adenocarcinoma of the rectum complemented by a wide pelvic lymphadenectomy. Twenty-seven consecutive patients with rectal carcinoma who underwent a surgical resection with conventional (Group I) or wide (Group II) pelvic lymphadenectomy were analyzed. Group I consisted of 10 patients (three women and seven men; mean age, 71 years) with tumors between 6 and 14 cm (mean, 10.6 cm) from the anal verge. Group II consisted of 17 patients (eight women and nine men; mean age, 67 years) with tumors between 3 and 14 cm (mean, 9 cm) from the anal verge. The choice of lymphadenectomy in association with colorectal resection was left at the discretion of the surgeon. There were no deaths within 60 days of operation. Mean intraoperative blood loss was the same in the two groups, although three patients (18 percent) required blood transfusions of over two liters during the performance of a wide pelvic lymphadenectomy in comparison with only one (10 percent) during conventional pelvic lymphadenectomy. The rate of early postoperative complications and the average length of postoperative hospital study were each similar between the two groups. After a wide pelvic lymphadenectomy, three (18 percent) patients developed a neurogenic bladder, requiring intermittent self-catheterization, and they all recovered within one, four, and eight months, respectively. Of the 16 males, three from Group I and four from Group II were sexually active and potent before surgical treatment; after recovering from surgery, only two patients from Group I regained their sexual potency. We conclude that the performance of a wide pelvic lymphadenectomy did not increase the intraoperative or early postoperative complication rate, the mean intraoperative blood loss, or the length of postoperative hospital stay. Technical refinements are currently under study to obviate the neurologic long-term complications.

Entities:  

Mesh:

Year:  1992        PMID: 1473415     DOI: 10.1007/bf02251965

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  Complications of perineal surgery.

Authors:  James W Ogilvie; Rocco Ricciardi
Journal:  Clin Colon Rectal Surg       Date:  2009-02

Review 2.  Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique.

Authors:  Miranda Kusters; Keisuke Uehara; Cornelis J H van de Velde; Yoshihiro Moriya
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.

Authors:  Ipek Sapci; Conor P Delaney; David Liska; Sudha Amarnath; Matthew F Kalady; Scott R Steele; Emre Gorgun
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

4.  Prophylactic lateral pelvic lymph node dissection in stage IV low rectal cancer.

Authors:  Hiroshi Tamura; Yoshifumi Shimada; Hitoshi Kameyama; Ryoma Yagi; Yosuke Tajima; Takuma Okamura; Mae Nakano; Masato Nakano; Masayuki Nagahashi; Jun Sakata; Takashi Kobayashi; Shin-Ichi Kosugi; Hitoshi Nogami; Satoshi Maruyama; Yasumasa Takii; Toshifumi Wakai
Journal:  World J Clin Oncol       Date:  2017-10-10

Review 5.  Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients.

Authors:  Gabriele Anania; Richard Justin Davies; Alberto Arezzo; Francesco Bagolini; Vito D'Andrea; Luigina Graziosi; Salomone Di Saverio; Georgi Popivanov; Isaac Cheruiyot; Roberto Cirocchi; Annibale Donini
Journal:  Int J Colorectal Dis       Date:  2021-06-14       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.